Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 0338-0008

3 FDA label images from Baxter Healthcare Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 0338-0008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Representative Structural Formula (Image 01)

Representative Structural Formula (Image 01)
Chemical structure diagram of Fosaprepitant Dimeglumine, showing the molecular composition of the active ingredient in the drug product Fosaprepitant injection powder for intravenous solution.*
FDA Label Image

Representative Vial Label (Image 02)

Representative Vial Label (Image 02)
Label for Fosaprepitant for Injection, 150 mg per vial, single-dose vial for intravenous use. The product is distributed by Baxter Healthcare Corporation, Deerfield, IL. Storage instructions specify refrigeration at 2-8°C (36-46°F) and stability details after reconstitution or dilution.*
FDA Label Image

Fosaprepitant Carton Label (Image 03)

Fosaprepitant Carton Label (Image 03)
Packaging label for Fosaprepitant for Injection 150 mg per vial, a sterile lyophilized powder for intravenous use. Label includes storage instructions, reconstitution with 5 mL of 0.9% Sodium Chloride, and cautions against use with divalent cation solutions. Manufactured for Baxter Healthcare Corporation, Deerfield, IL. Barcode and NDC 0338-0008 are displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.